Benzinga's Top Initiations

Analysts at Stifel Nicolaus initiated coverage on CoLucid Pharmaceuticals Inc CLCD with a Buy rating. The target price for CoLucid Pharmaceuticals is set to $15. CoLucid Pharmaceuticals' shares closed at $8.68 on Friday. Analysts at JP Morgan initiated coverage on aTyr Pharma Inc LIFE with a Overweight rating. aTyr Pharma shares closed at $22.89 on Friday. Analysts at Cowen & Company initiated coverage on Adaptimmune Therapeutics PLC – ADR ADAP with a Outperform rating. Adaptimmune Therapeutics' shares closed at $15.43 on Friday. Leerink Swann initiated coverage on Fate Therapeutics Inc FATE with a Outperform rating. The target price for Fate Therapeutics is set to $10. Fate Therapeutics' shares closed at $6.26 on Friday. Analysts at Jefferies initiated coverage on Collegium Pharmaceutical Inc COLL with a Buy rating. The target price for Collegium Pharmaceutical is set to $20. Collegium Pharmaceutical's shares closed at $17.00 on Friday. Goldman Sachs initiated coverage on Tallgrass Energy GP LP TEGP with a Neutral rating. The target price for Tallgrass Energy is set to $35. Tallgrass Energy shares closed at $32.06 on Friday. Analysts at UBS initiated coverage on Prothena Corporation PLC PRTA with a Buy rating. The target price for Prothena Corporation is set to $58. Prothena Corporation shares closed at $39.44 on Friday. Bernstein initiated coverage on PetroChina Company Limited (ADR) PTR with a Underperform rating. PetroChina shares closed at $118.49 on Friday. Analysts at Oppenheimer initiated coverage on Affimed NV AFMD with a Outperform rating. The target price for Affimed is set to $14. Affimed shares closed at $10.43 on Friday. Morgan Stanley initiated coverage on Vanguard Natural Resources, LLC VNR with a Overweight rating. The target price for Vanguard Natural is set to $20. Vanguard Natural shares closed at $15.88 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!